Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0001106578-25-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-02 | 2025-12-01+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $481.61 | -8,000 | 1,861 | -81% | -$3.85M |
| DMT | 2025-12-02 | 2025-12-01+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-02 | 2025-12-01+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -8,000 | 50.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | S | D | 1,590 | $480.28 | 2,540 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $480.055 to $481.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-12-01 | S | D | 1,390 | $482.28 | 1,150 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $482.01 to $482.8375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-12-01 | S | D | 520 | $483.38 | 630 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-01 | S | D | 500 | $484.68 | 130 | D | — | — | |
| 5 | Common | Common Stock | 2025-12-01 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-02 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 7 | Common | Common Stock | 2025-12-02 | S | D | 1,731 | $482.95 | 130 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $482.55 to $483.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2025-12-02 | S | D | 1,000 | $478.64 | 3,130 | D | — | — | |
| 9 | Common | Common Stock | 2025-12-02 | S | D | 500 | $480.14 | 2,630 | D | — | — | |
| 10 | Common | Common Stock | 2025-12-02 | S | D | 769 | $481.72 | 1,861 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $481.41 to $482.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Derivative | Stock Option | 2025-12-01 | M | D | 4,000 | $0.00 | 54,000 | D | $120.26 · 2020-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 12 | Derivative | Stock Option | 2025-12-02 | M | D | 4,000 | $0.00 | 50,000 | D | $120.26 · 2020-03-15 to 2026-03-15 | 4,000 Common Stock |